PDL BioPharma Inc.’s (PDLI) MACD indicator has moved into bearish territory with a reading of –0.0316. The Zacks #4 Rank (“Sell”) stock decreased more than 1.57% to $7.52 in morning trade. The Zacks Consensus Estimate on the company’s earnings for the year ending December 2012 has decreased by 6 cents over the past month to $1.41 per share.
PDL BIOPHARMA (PDLI): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment